Vaxart (VXRT) Financials

$0.49

$0.00 (0.20%)

As on 04-Sep-2026 15:39EDT

Market cap

$122 Mln

Revenue (TTM)

$243 Mln

P/E Ratio

2.9

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	243.06	237.26	28.70	7.38	0.11	0.89
Cost of Revenue	22.76	--	4.40	4.50	3.27	48.75
Gross Profit	243.06	237.26	28.70	2.88	0.11	-47.86
Operating Expenses	203.45	219.18	94.99	86.23	114.69	24.90
Operating Profit (EBIT)	39.61	18.07	-66.29	-83.35	-114.59	-72.75
Other Income	--	--	--	--	-0.01	0.00
Profit before Tax	39.01	16.80	-66.69	-82.20	-107.69	-70.36
Provision for Tax	0.42	0.48	0.26	0.26	0.07	0.11
Profit after Tax (Net Income)	38.59	16.33	-66.95	-82.47	-107.76	-70.47
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-107.76	-70.47

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	82.37	87.80	58.93	57.81	110.60	187.53
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	9.71	11.53	16.59	20.30	25.33	22.85
Current Liabilities	73.11	86.75	90.88	13.72	17.92	10.78
Total Liabilities	238.29	186.08	166.39	91.83	153.85	221.17

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	48.49	49.96	98.13	46.29	54.40	52.00
Current Assets	116.69	136.12	68.26	45.54	99.45	169.17
Total Assets	238.29	186.08	166.39	91.83	153.85	221.17
Total Debt*	7.81	8.99	23.28	26.51	27.42	24.53
Net Current Assets	43.58	49.37	-22.62	31.81	81.53	158.38

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	7.71	-44.76	-70.45	-94.78	-59.83
Cash Flow from Investing Activities	--	16.63	-21.32	43.95	-20.42	-49.10
Cash from Financing Activities	--	4.24	56.56	15.24	17.46	125.80
Net Cash Inflow / Outflow	--	--	--	--	-97.73	16.88

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.17	0.07	-0.29	-0.47	-0.61	-0.41
Cash EPS ($)	--	0.11	-0.26	-0.42	-0.57	-0.39
Adjusted Book Value ($)	--	0.38	0.26	0.33	0.62	1.10
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.03	-0.20	-0.40	-0.53	-0.35
Free Cash Flow per Share ($)	--	0.03	-0.20	-0.41	-0.59	-0.38

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	18.24	-80.40	-74.18	-61.56	-39.41
ROE (%)	45.35	22.26	-114.71	-97.94	-72.29	-45.33
ROA (%)	14.83	9.26	-51.85	-67.13	-57.47	-37.71
EBIT Margin (%)	16.95	8.27	-222.02	-1,094.42	-99,426.17	-7,722.31
Net Margin (%)	15.88	6.88	-233.27	-1,117.56	-106,691.09	-7,909.09
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	201.11	7.27	2.89	67.96	-0.88	-0.78
EBIT Growth (%)	177.59	130.80	21.10	24.09	-54.44	-128.79
Net Profit Growth (%)	168.13	124.39	18.82	23.47	-52.91	-118.72
EPS Growth (%)	163.55	1.24	0.37	0.23	-0.48	-1.19
Book Value Growth (%)	136.26	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	2.94	4.85	-2.25	-1.23	-1.58	-15.22
Price / Book Value	1.45	0.90	2.56	1.76	1.54	5.72
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.35	0.87	-2.23	-1.23	-1.04	-14.00
Close Price ($)	0.57	0.34	0.66	0.57	0.96	6.27
High Price ($)	0.84	0.98	1.54	1.59	6.80	24.90
Low Price ($)	0.26	0.26	0.52	0.53	0.73	4.86
Market Cap ($ Cr)	121.59	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.10	0.40	0.46	0.25	0.13
Short term debt to equity ratio	0.03	0.03	0.12	0.11	0.02	0.01
Current Ratio	1.60	1.57	0.75	3.32	5.55	15.69
Quick Ratio	1.60	--	--	3.32	5.44	15.69
Interest Coverage	18.76	6.95	-21.46	-55.81	-81.52	-46.54

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	19.33	21.64	41.70	40.76	18.69	7.96
Asset Turnover	0.93	1.35	0.22	0.06	0.00	0.00
Receivable days	--	48.73	95.30	74.94	155.32	82.92
Inventory Days	--	--	0.00	81.17	111.80	0.82
Payable days	--	--	354.75	288.06	524.68	22.50
Cash Conversion Cycle	--	--	-259.45	-131.95	-257.56	61.24

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.